Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP586183.RAEMAFT_jpa0cxuYmUmbbwojJfmoWpu8ZlAN-JMmKRRKA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP586183.RAEMAFT_jpa0cxuYmUmbbwojJfmoWpu8ZlAN-JMmKRRKA130_assertion type Assertion NP586183.RAEMAFT_jpa0cxuYmUmbbwojJfmoWpu8ZlAN-JMmKRRKA130_head.
- NP586183.RAEMAFT_jpa0cxuYmUmbbwojJfmoWpu8ZlAN-JMmKRRKA130_assertion description "[We conducted a hospital-based case-control study including 727 cases and 736 healthy controls to evaluate the associations of the polymorphic phase-I and -II biotransformations (CYP1A1, CYP1A2, GSTM1, GSTT1, GSTP1, NAT1 and NAT2) and DNA-repair enzymes (XRCC1, XRCC3 and XPD) with the risk of contracting colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP586183.RAEMAFT_jpa0cxuYmUmbbwojJfmoWpu8ZlAN-JMmKRRKA130_provenance.
- NP586183.RAEMAFT_jpa0cxuYmUmbbwojJfmoWpu8ZlAN-JMmKRRKA130_assertion evidence source_evidence_literature NP586183.RAEMAFT_jpa0cxuYmUmbbwojJfmoWpu8ZlAN-JMmKRRKA130_provenance.
- NP586183.RAEMAFT_jpa0cxuYmUmbbwojJfmoWpu8ZlAN-JMmKRRKA130_assertion SIO_000772 17191090 NP586183.RAEMAFT_jpa0cxuYmUmbbwojJfmoWpu8ZlAN-JMmKRRKA130_provenance.
- NP586183.RAEMAFT_jpa0cxuYmUmbbwojJfmoWpu8ZlAN-JMmKRRKA130_assertion wasDerivedFrom befree-2016 NP586183.RAEMAFT_jpa0cxuYmUmbbwojJfmoWpu8ZlAN-JMmKRRKA130_provenance.
- NP586183.RAEMAFT_jpa0cxuYmUmbbwojJfmoWpu8ZlAN-JMmKRRKA130_assertion wasGeneratedBy ECO_0000203 NP586183.RAEMAFT_jpa0cxuYmUmbbwojJfmoWpu8ZlAN-JMmKRRKA130_provenance.